FEDERATED HERMES, INC. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2023$27,964
-42.4%
1,140
-45.3%
0.00%
Q1 2023$48,541
+6.5%
2,086
+15.9%
0.00%
Q4 2022$45,558
-99.0%
1,800
-99.2%
0.00%
-100.0%
Q3 2022$4,587,000
+229250.0%
237,913
+321404.1%
0.01%
Q1 2022$2,000
-99.8%
74
-99.7%
0.00%
-100.0%
Q1 2020$893,00026,0580.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders